Conmed (NYSE:CNMD) reported quarterly earnings of $1.15 per share which beat the analyst consensus estimate of $1.12 by 2.4 percent. This is a 17.35 percent increase over earnings of $0.98 per share from the same period last year. The company reported quarterly sales of $342.345 million which beat the analyst consensus estimate of $338.167 million by 1.24 percent. This is a 3.09 percent increase over sales of $332.097 million the same period last year.